Penbactam for Helicobacter pylori eradication: A randomised comparison of quadruple and triple treatment schedules in an Iranian population

Arab Journal of Gastroenterology

Volumn 14, Issue 1, 2013, Pages 1-5

  Seyedmajidi, Seyedali ^a   Mirsattari, Dariush ^b   Zojaji, Homayoun ^b   Zanganeh, Elahe ^c   Seyyedmajidi, Mohammadreza ^a   Almasi, Shohreh ^b   Zali, Mohammadreza ^b  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c K N TOOSI UNIVERSITY OF TECHNOLOGY   (Iran)

Author keywords

Helicobacter pylori; Penbactam; Treatment

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; PENBACTAM; UNCLASSIFIED DRUG; UREA C 13;

ABDOMINAL PAIN; ABNORMAL FECES; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; COUGHING; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DYSPEPSIA; ERADICATION THERAPY; FECES; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PEPTIC ULCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER; UREA BREATH TEST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; AMPICILLIN; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BREATH TESTS; CLARITHROMYCIN; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRAN; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PEPTIC ULCER; PROTON PUMP INHIBITORS; SULBACTAM; UREA; YOUNG ADULT;

EID: 84876879190     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2012.12.004     Document Type: Article

References (26)

1. Gené E., Calvet X., Azagra R., et al. Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis. Alimen Pharmacol Therap 2003, 17(9):1137-1143.
2. Katelaris P.H., Forbes G.M., Talley N.J., et al. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: the quadrate study. Gastroenterology 2002, 123(6):1763-1769.
3. Laine L., Hunt R., El Zimaity H., et al. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole and tetracycline given with omeprazole versus omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial. Am J Gastroenterol 2003, 98(3):562-567.
4. Laine L. Is it time for quadruple therapy to be first line?. Helicobacter pylori: basic mechanisms to clinical cure 2002, 347-351. Kluwer Academic Publishers, Dordrecht. R.H. Hunt, G.N.J. Tytgat (Eds.).
5. Calvet X., Ducons J., Guardiola J., et al. One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial. Alimen Pharmacol Therap 2002, 16(7):1261-1267.
6. Gomollón F., Valdepérez J., Garuz R., et al. Cost/effectiveness analysis of two strategies for Helicobacter pylori eradication: results of a prospective and randomized study in primary care setting [analisis coste-efectividad de dos estrategias de erradicacion de Helicobacter pylori: resultados de un estudio prospectivo y aleatorizado en atencion primaria]. Med Clin 2000, 115(1):1-6.
7. Ching S.S., Sabanathan S., Jenkinson L.R. Treatment of Helicobacter pylori in surgical practice. A randomised trial of triple versus quadruple therapy in a rural district general hospital. World J Gastroenterol 2008, 14(24):3855-3860.
8. Fischbach L.A., Van Zanten S.V., Dickason J. Meta-analysis: the efficacy, adverse events and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Alimen Pharmacol Therap 2004, 20(10):1071-1082.
9. Choung R.S., Lee S.W., Jung S.W., et al. Comparison of the effectiveness of quadruple salvage regimen for Helicobacter pylori infection according to the duration of treatment. Korean J Gastroenterol 2006, 47(2):131-135.
10. Jang H.J., Choi M.H., Kim Y.S., et al. Effectiveness of triple therapy and quadruple therapy for Helicobacter pylori eradication. Korean J Gastroenterol 2005, 46(5):368-372.
11. Magaret N., Burm M., Faigel D., et al. A randomized trial of lansoprazole, amoxycillin and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy. Dig Dis 2001, 19(2):174-178.
12. Uygun A., Kadayifci A., Safali M., et al. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori. J Dig Dis 2007, 8(4):211-215.
13. Van Der Hulst R.W.M., Keller J.J., Rauws E.A.J., et al. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996, 1(1):6-19.
14. Georgopoulos S.D., Ladas S.D., Karatapanis S., et al. Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies. Alimen Pharmacol Therap 2002, 16(3):569-575.
15. Lee J.H., Cheon J.H., Park M.J., et al. The trend of eradication rates of second-line quadruple therapy containing metronidazole for Helicobacter pylori infection: an analysis of recent eight years. Korean J Gastroenterol 2005, 46(2):94-98.
16. Mirbagheri S.A., Hasibi M., Abouzari M., et al. Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial. World J Gastroenterol 2006, 12(30):4888-4891.
17. Nash C., Fischbach L., Veldhuyzen van Zanten S. What are the global response rates to Helicobacter pylori eradication therapy?. Can J Gastroenterol 2003, 17(Suppl. B):25B-29B.
18. Thong Ngam D., Mahachai V. 14-Day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand. J Med Assoc Thai 2006, 89(Suppl. 3):S119-S125.
19. Calvet X., García N., López T., et al. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. Alimen Pharmacol Therap 2000, 14(5):603-609.
20. Calvet X., Garcia N., Gené E., et al. Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment. Alimen Pharmacol Therap 2001, 15(7):1061-1065.
21. Dore M.P., Graham D.Y., Mele R., et al. Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection. Am J Gastroenterol 2002, 97(4):857-860.
22. Graham D.Y., Osato M.S., Hoffman J., et al. Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study. Alimen Pharmacol Therap 2000, 14(6):745-750.
23. Michopoulos S., Tsibouris P., Bouzakis H., et al. Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens. Alimen Pharmacol Therap 2000, 14(6):737-744.
24. Malfertheiner P., Megraud F., O'Morain C., et al. Current concepts in the management of Helicobacter pylori infection: the maastricht III consensus report. Gut 2007, 56(6):772-781.
25. Vilaichone R.K., Mahachai V., Graham D.Y. Helicobacter pylori diagnosis and management. Gastroenterol Clin North Am 2006, 35(2):229-247.
26. Seyyedmajidi M., Falaknazi K., Mirsattari D., et al. Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: a randomised clinical trial. Arab J Gastroenterol 2011, 12(3):150-153.